CD169+ Macrophages Take the Bullet

nEWs and ViEWs 1. Fazilleau, N. et al. Immunity 30, 324–335 could sustain the presence of NKTFH cell– assessed mainly for their ability to induce strong (2009). dependent germinal centers. T helper type 1 or 2 or tolerogenic immune 2. Nutt, S.L. et al. Nat. Immunol. 12, 472–477 The new insights gained from these studies responses according to the therapeutic objec- (2011). could lead to the design of complex antigen for- tives. It will be important to assess the effect 3. Galli, G. et al. Proc. Natl. Acad. Sci. USA 104, 3984–3989 (2007). mulations that combine lipid-protein antigen of iNKT cell agonists on inducing IL-21 pro- 4. Chang, P. et al. Nat. Immunol. 13, 35–43 (2012). with T cell epitopes to prime not only B cells duction by iNKT cells to promote not only 5. King, I. et al. Nat. Immunol. 13, 44–50 (2012). 6. Cerundolo, V. et al. Nat. Rev. Immunol. 9, 28–38 but also T cells. This strategy would boost not B cell help but also a different spectrum of (2009). only iNKT cells but also conventional T cell cytokines such as IL-4 or interferon-γ, which 7. Tupin, E. et al. Nat. Rev. Microbiol. 5, 405–417 responses through the activation of dendritic are known to drive isotype switching to (2007). 8. Diana, J. et al. Eur. J. Immunol. 39, 3283–3291 cells. This strategy would combine the antigen- IgG1 and IgG2a, respectively. Modifying the (2009). specific iNKT cell cognate help provided to lipid covalently coupled to protein antigen 9. Diana, J. et al. Immunity 30, 289–299 (2009). 10. Schwickert, T.A. et al. J. Exp. Med. 206, 2907–2914 B cells plus the adjuvant effect of iNKT cells could affect iNKT cell function and therefore (2009). through dendritic cells. Considerable effort has antigen-specific immune responses. 11. Allen, D. et al. EMBO J. 7, 1995–2001 (1988). been expended in synthesizing new iNKT cell 12. Belperron, A.A. et al. J. Immunol. 174, 5681–5686 (2005). agonists that stimulate various aspects of iNKT COMPETING FINANCIAL INTERESTS 13. Hansen, D.S. et al. Eur. J. Immunol. 33, 2588–2598 cell functions. At present, these ligands are The authors declare no competing financial interests. (2003). CD169+ macrophages take the bullet Burkhard Ludewig & Luisa Cervantes-Barragan Lifting the protective shield provided by the type I interferon system selectively in CD169+ splenic macrophages enforces localized viral replication. Such controlled release of virus amplifies adaptive antiviral immune responses. ype 1 interferons are pleiotropic cyto via the Jak-STAT signal-transduction path- have additional functions4. Indeed, Usp18 Tkines that secure an important first line way. Two members of the Jak family of interferes with the binding of Jak1 to IFNAR2 of defense against viral infection. As many kinases, Tyk2 and Jak1, bind to the IFNAR1 and hence acts as a negative regulator of type I viruses replicate rapidly, the interferon system and IFNAR2 subunits, respectively, and form interferon signaling5 (Fig. 1c). Consequently, must react swiftly to control viral replication a signal-transducing heterodimer (Fig. 1b). deletion of Usp18 results in improved survival in infected cells and to limit viral dissemina- A phosphorylation cascade facilitates the bind- of mice infected intracranially with lympho- tion to as-yet-uninfected cells. Mammalian ing of STAT1-STAT2 to the IFNAR proteins cytic choriomeningitis virus or VSV6 because cells not only produce type I interferons under and subsequent translocation of a complex of in these infection models, larger amounts of Nature America, Inc. All rights reserved. All rights Inc. America, Nature certain conditions but also respond to these STAT1, STAT2 and the transcription factor locally produced type I interferon lead to bet- 2 cytokines, because the IFNAR receptor for IRF9 to the nucleus. The binding of this com- ter control of viral replication in the central type I interferon is expressed ubiquitously. plex to the interferon-stimulated response nervous system. Likewise, the enhanced type I © 201 Thus, the interferon system can be seen as a elements in the promoter regions of interferon- interferon response in Usp18-deficient mice broadly protective shield that generates and stimulated genes (ISGs) leads to the production confers more efficient protection against infec- maintains the ‘antiviral state’ during the early of intracellular effectors that directly counteract tion with Salmonella typhimurium. However, phase of viral infection. In this issue of Nature viral replication2. Honke et al. now show that such unleashed type I interferon production Immunology, Honke et al. describe upregula- the cell type–specific and context-dependent can also precipitate hypersensitivity to lipo tion of the ubiquitin-specific protease Usp18 regulation of type I interferon signaling in polysaccharide-induced immunopathology7. as a mechanism that lifts the protective type I CD169+ macrophages of the marginal zone Thus, the tight regulation of type I interferon interferon shield selectively in CD169+ macro via Usp18 secures survival after infection with signaling via Usp18 might also be critical for phages in the splenic marginal zone and thus vesicular stomatitis virus (VSV)1. Usp18 was reaching a protective balance between the enforces locally restricted production of virus initially described as an enzyme that decon- innate response to a pathogen and infection- to make antigen available for the generation jugates the interferon-induced protein ISG15; associated immunopathology. and maintenance of protective, virus-specific Usp18 is upregulated in cells by type I inter- The retention and sampling of infectious T cells and B cells1 (Fig. 1). ferons or lipopolysaccharide. The conjugation agents in specialized zones of secondary lym- After type I interferons bind to their recep- of proteins encoded by ISGs of ISG15 to other phoid organs is a critical step in the initiation tors on the cell surface, signals are transduced has been shown to be important for antiviral of immune responses8. In the spleen, the mar- defense in some infections, such as infection ginal zone efficiently filters pathogens from Burkhard Ludewig is with the Institute of with Sindbis virus3. As a consequence, it was the blood (Fig. 1). The macrophages of the Immunobiology, Kantonal Hospital St. Gallen, proposed that Usp18 would interfere with the marginal zone that express the C-type lectin St. Gallen, Switzerland. Luisa Cervantes-Barragan antiviral response by deconjugating ISG15. CD169 (recognized by the monoclonal anti- is in the Department of Pathology and Immunology, However, only the lack of Usp18, but not the body MOMA-1) are also known as ‘metal- Washington University School of Medicine, lack of ISG15, results in greater susceptibility to lophilic macrophages’. Similar to splenic St. Louis, Missouri, USA. infection with lymphocytic choriomeningitis CD169+ macrophages of the marginal zone1, e-mail: [email protected] virus or VSV, which suggests that Usp18 might CD169+ subcapsular macrophages of lymph NATURE IMMUNOLOGY VOLUME 13 NUMBER 1 JANUARY 2012 13 nEWs and ViEWs Red pulp Marginal zone that the early events in the antigen-sampling zones of secondary lymphoid organs, such as IFNα/β B cell the subcapsular sinus in lymph nodes or the IFNAR2 IFNAR1 splenic marginal zone, are decisive for the out- d come of antimicrobial immune responses9–11. IFNα/β Presentation Nevertheless, important issues still remain to Usp18 Tyk2 IFNAR2 IFNAR1 to B cells be addressed, such as how viral particles are Jak1 a STAT1STAT2 transferred to classical dendritic cells in the T cell zone, and how viruses are contained by Jak1 Tyk2 c No IFN I + VSV signaling CD169 macrophages in the splenic marginal STAT1 STAT2 Usp18 T cell zone or the lymph node subcapsular sinus. IRF9 We predict that the various myeloid cells of Enforced viral antigen-sampling zones of the secondary lym- d + CD169+ replication phoid organs (that is, CD169 macrophages b macrophage and plasmacytoid and classical dendritic cells) Antiviral DC response Antigen production provide the appropriate ‘tuning devices’ to facil- ISGs for T cell priming itate controlled release of live virus, either alone or in concert with other cells. However, viruses No viral replication may have developed counter mechanisms to Blood interfere with the selectively enforced viral rep- F4/80+ macrophage Katie Vicari Katie lication to remain ‘under the radar’ of the adaptive immune system12. Future studies should + Figure 1 Inhibition of type I interferon signaling in CD169 macrophages of the marginal zone characterize these intracellular regulatory and through Usp18 enforces local virus production and improves activation of antiviral T cell and B cell responses. (a) After systemic infection with VSV, viral particles enter the spleen via the blood stream counter-regulatory circuits. Such studies will and ‘preferentially’ infect F4/80+ macrophages in the red pulp and CD169+ macrophages in the deliver important information for vaccine marginal zone. (b) Type I interferons trigger a potent antiviral intracellular response via IFNAR in development, because targeting of antigen to F4/80+ macrophages of the red pulp to control the viral infection. (c) In contrast, CD169+ macrophages and ‘tuning’ of innate effectors in the antigen- ‘take the bullet’, as Usp18-mediated inhibition of type I interferon signaling enforces viral replication in sampling zone are critical for the induction of these cells. Usp18 functions as a negative regulator of type I interferon signaling by interfering with the protective adaptive immune responses. Finally, binding of Jak1 to IFNAR2. (d) The production of live virus by CD169+ macrophages facilitates direct antigen presentation of virus to B cells and generates sufficient antigen for processing and presentation the study of Honke et al. provides, at least in via classical dendritic cells (DCs) for T cell priming. part, an explanation for the finding that attenu- ated live vaccines generally elicit better protection than do inactivated or subunit vaccines1. nodes capture and retain VSV9,10.

Load more